Copyright
©The Author(s) 2024.
World J Clin Cases. Jul 16, 2024; 12(20): 4247-4255
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4247
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4247
Table 1 Sleep quality survey results of gastrointestinal malignant tumor chemotherapy patients
Cancer types | n | PSQI score (points) | Number of sleep disorders | Incidence of sleep disorders (%) | |||
Mild | Moderate | Severe | Total | ||||
Gastrointestinal malignant tumor | 131 | 10.52 ± 1.07 | 41 | 26 | 11 | 78 | 59.54 |
Rectal cancer | 22 | 9.31 ± 0.96 | 9 | 7 | 3 | 19 | 86.36 |
Colon cancer | 13 | 9.19 ± 0.94 | 6 | 4 | 1 | 11 | 84.62 |
Gastric cancer | 33 | 11.18 ± 1.46a,b | 8 | 5 | 3 | 16 | 48.48a,b |
Esophageal cancer | 63 | 10.87 ± 1.72a,b | 18 | 10 | 4 | 32 | 50.79a,b |
F/χ2 | 11.621 | 13.639 | |||||
P value | < 0.001 | 0.003 |
Table 2 Comparison of data between the sleep disorder group and the normal sleep group
Variables | Group | Sleep disorders group (n = 78) | Normal sleep group (n = 53) | χ2/t | P value |
Sex | Male | 62 (79.49) | 38 (71.70) | 1.060 | 0.303 |
Female | 16 (20.51) | 15 (28.30) | |||
Age | - | 68.74 ± 6.95 | 64.82 ± 6.56 | 3.241 | < 0.001 |
Educational level | Junior high school and below | 36 (46.15) | 25 (47.17) | 0.013 | 0.909 |
High school and above | 42 (53.85) | 28 (52.83) | |||
Residence | Town | 48 (61.54) | 33 (62.26) | 0.007 | 0.933 |
Rural | 30 (38.46) | 20 (37.74) | |||
Chemotherapy regimen | FOLFOXIRI | 45 (57.69) | 32 (60.38) | 0.094 | 0.759 |
FOLFOX | 33 (42.31) | 21 (39.62) | |||
Chemotherapy frequency | ≤ 6 | 68 (87.18) | 52 (98.11) | 4.905 | 0.027 |
> 6 | 10 (12.82) | 1 (1.89) | |||
Pain level | Mild | 68 (85.90) | 52 (98.11) | - | 0.0361 |
Moderate | 9 (12.82) | 1 (1.89) | |||
Severe | 1 (1.28) | 0 (0) | |||
SAS score | - | 57.43 ± 5.86 | 46.62 ± 4.58 | 11.286 | < 0.001 |
SDS score | - | 58.17 ± 5.69 | 44.23 ± 4.75 | 14.689 | < 0.001 |
Ward noise | Yes | 30 (38.46) | 10 (18.87) | 5.712 | 0.017 |
No | 48 (61.54) | 43 (81.13) |
Table 3 Comparison of Mishel Uncertainty in Illness Scale for Adults scores between sleep disorder group and normal sleep group (mean ± SD)
Group | Lack of disease information | Disease uncertainty | Complexity | Unpredictability | Total score |
Sleep disorders group (n = 78) | 16.57 ± 1.68 | 46.25 ± 4.72 | 24.75 ± 2.54 | 10.13 ± 1.16 | 97.76 ± 9.82 |
Normal sleep group (n = 53) | 13.26 ± 1.57 | 30.57 ± 3.26 | 16.54 ± 1.79 | 8.15 ± 0.83 | 68.53 ± 6.90 |
t | 11.362 | 21.007 | 20.338 | 10.699 | 18.743 |
P value | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
Table 4 Comparison of Connor-Davidson Resilience Scale scores between sleep disorder group and normal sleep group (mean ± SD)
Group | Resilience | Self-improvement | Optimistic | Total score |
Sleep disorders group (n = 78) | 25.48 ± 2.63 | 17.15 ± 1.78 | 5.71 ± 0.61 | 48.32 ± 4.96 |
Normal sleep group (n = 53) | 28.63 ± 2.97 | 18.96 ± 1.93 | 6.34 ± 0.65 | 53.93 ± 5.46 |
t | 6.383 | 5.520 | 5.650 | 6.099 |
P value | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
Table 5 Correlation between Pittsburgh Sleep Quality Index score and Mishel Uncertainty in Illness Scale for Adults and Connor-Davidson Resilience Scale scores in chemotherapy patients with gastrointestinal malignant tumors
Variables | PSQI | ||
r | P value | ||
MUIS-A score | Lack of disease information | 0.583 | < 0.001 |
Disease uncertainty | 0.422 | 0.008 | |
Complexity | 0.169 | 0.114 | |
Unpredictability | 0.426 | 0.006 | |
CD-RISC score | Resilience | -0.579 | < 0.001 |
Self-improvement | -0.613 | < 0.001 | |
Optimistic | -0.281 | 0.021 |
Table 6 Analysis of Factors Influencing Sleep Disorders in Chemotherapy Patients with Gastrointestinal Malignant Tumors
Factors | β | SE | Wald χ2 | OR | P value | 95%CI |
Age | 0.353 | 0.276 | 1.636 | 1.423 | 0.202 | 0.829-2.445 |
Chemotherapy frequency | 0.255 | 0.184 | 1.921 | 1.290 | 0.167 | 0.900-1.851 |
Pain level | 0.457 | 0.273 | 2.802 | 1.579 | 0.095 | 0.925-2.697 |
SAS score | 0.291 | 0.115 | 6.403 | 1.338 | 0.012 | 1.068-1.676 |
SDS score | 0.284 | 0.118 | 5.793 | 1.328 | 0.017 | 1.054-1.674 |
Ward noise | 0.365 | 0.176 | 4.301 | 1.441 | 0.039 | 1.020-2.034 |
MUIS-A score | 0.357 | 0.148 | 5.819 | 1.429 | 0.016 | 1.069-1.910 |
CD-RISC score | -0.426 | 0.106 | 16.151 | 0.653 | < 0.001 | 0.531-0.804 |
- Citation: Tang WW, Han ML, Xu SH, Deng YX, Shen Q. Analysis of sleep quality, disease uncertainty, and psychological tolerance in patients undergoing chemotherapy for digestive tract malignancies. World J Clin Cases 2024; 12(20): 4247-4255
- URL: https://www.wjgnet.com/2307-8960/full/v12/i20/4247.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i20.4247